MXCT (MaxCyte, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of May 21, 2026, MXCT trades at $1.07 with a market cap of $113.55M and a P/E ratio of -2.49. MXCT moved +1.44% today. Year to date, MXCT is -30.97%; over the trailing twelve months it is -50.92%. Its 52-week range spans $0.64 to $5.20. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns MXCT stock?
Hedge funds tracked by Rallies that own MXCT include Centerbook Partners and Chilton Investment. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MaxCyte, Inc. Common Stock.
MXCT Key Metrics
Key financial metrics for MXCT
Metric
Value
Price
$1.07
Market Cap
$113.55M
P/E Ratio
-2.49
EPS
$-0.42
Dividend Yield
0.00%
52-Week High
$5.20
52-Week Low
$0.64
Volume
0
Avg Volume
0
Revenue (TTM)
$33.03M
Net Income
$-44.63M
Gross Margin
81.16%
Top Hedge Funds Holding MXCT
Centerbook Partners holds 717.27K shares of MXCT, changed -17.27% as of Mar 31, 2025.
Chilton Investment holds 21.93K shares of MXCT, changed +0.00% as of Dec 31, 2023.
Hedge funds tracked by Rallies that own MXCT include Centerbook Partners and Chilton Investment. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MaxCyte, Inc. Common Stock.
Does Rallies show 13F holders for MXCT?
Yes. Rallies tracks hedge fund and 13F ownership data for MXCT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MXCT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MXCT. It does not provide personalized investment advice.
